Breaking
Vaccine breakthrough stops cancer returning in trial Gwyneth Paltrow allegedly set to throw dinner in honor of Sam Altman NASA mission to save its sinking space telescope fails OpenAI seeks to one-up Anthropic with new customer privacy protections Chinese Valentine’s Day is rooted in legend and tradition, not just romance UC Berkeley professor admits to using AI to edit op-ed on students’ math skills Prince Harry emphasizes need to better apply veterans’ skills during roundtable with service members Chinese court sentences Evergrande founder to life in prison for fraud Smuggling in Gaza: How banned goods make it across the border and millions of dollars change hands Judge will consider new trial for Karmelo Anthony in Texas track meet killing
NEWSREEL
The day, in 30-second reels.
--:--:--
World / Reel
World · Video brief

Woman with three deadly diseases has ‘remarkable’ recovery after cell therapy

A 47-year-old woman with three autoimmune diseases experiences a stunning recovery after undergoing CAR T-cell therapy. Previously resistant to nine other treatments, she now enjoys a treatment-free remission thanks to this groundbreaking p...

The Guardian· Apr 10, 2026 · 3:17 AM · 30 views

Video won't play? Watch on YouTube →

A 47-year-old woman with three autoimmune diseases experiences a stunning recovery after undergoing CAR T-cell therapy. Previously resistant to nine other treatments, she now enjoys a treatment-free remission thanks to this groundbreaking procedure. This therapy could pave the way for new treatments in autoimmune diseases. #HealthBreakthrough #ImmuneTherapy #MedicalInnovation

Originally reported by The Guardian. Read the full story →

More in World

World World
World

Chinese court sentences Evergrande founder to life in prison for fraud

AP News· 1 hour ago
World World
World

Rachel Roddy’s recipe for spaghetti with semi-dried tomatoes, garlic, herbs and breadcrumbs | A kitchen in Rome

The Guardian· 1 hour ago
World World
World

Four workers dead after being hit by train in Japan

BBC News· 1 hour ago

0 Comments

No comments yet. Be the first.